{"transactions":[{"id":3392380,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":154409,"kind":"person","name":"Miller Eric Alejandro","position":1,"cik":"0001758494","reported_name":"Miller Eric Alejandro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Controller & PAO"}}],"security":"Restricted Stock Units","published_at":"2019-10-17T22:26:38.000Z","date":"2019-10-15","kind":"exercise","acquired":false,"shares":417,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning 10/15/19."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning 10/15/19."}],"balance_after":1254,"derivative":{"underlying":"Common Stock","underlying_shares":417},"source":{"system":"sec-edgar","filing":"0001209191-19-053494","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919119053494/doc4.xml","form_type":"4"}},{"id":3392379,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":154409,"kind":"person","name":"Miller Eric Alejandro","position":1,"cik":"0001758494","reported_name":"Miller Eric Alejandro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Controller & PAO"}}],"security":"Common Stock","published_at":"2019-10-17T22:26:38.000Z","date":"2019-10-15","kind":"sale","acquired":false,"shares":147,"price":39.65,"value":5828.55,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were made to cover the tax obligation that occurred upon the vesting of restricted stock units."}],"balance_after":270,"source":{"system":"sec-edgar","filing":"0001209191-19-053494","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919119053494/doc4.xml","form_type":"4"}},{"id":3392378,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":154409,"kind":"person","name":"Miller Eric Alejandro","position":1,"cik":"0001758494","reported_name":"Miller Eric Alejandro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Controller & PAO"}}],"security":"Common Stock","published_at":"2019-10-17T22:26:38.000Z","date":"2019-10-15","kind":"exercise","acquired":true,"shares":417,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":417,"source":{"system":"sec-edgar","filing":"0001209191-19-053494","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919119053494/doc4.xml","form_type":"4"}},{"id":3417838,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":154409,"kind":"person","name":"Miller Eric Alejandro","position":1,"cik":"0001758494","reported_name":"Miller Eric Alejandro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Controller & PAO"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-09-11T23:19:29.000Z","date":"2019-09-09","kind":"exercise","acquired":false,"shares":1972,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"25% of the shares subject to the Stock Option vest and become exercisable on April 7, 2019, and the remaining shares vest and become exercisable in 36 equal monthly installments thereafter."}],"balance_after":3598,"derivative":{"exercise_price":16.5,"expiration_date":"2028-04-06","underlying":"Common Stock","underlying_shares":1972},"source":{"system":"sec-edgar","filing":"0001209191-19-049231","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919119049231/doc4.xml","form_type":"4"}},{"id":3417837,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":154409,"kind":"person","name":"Miller Eric Alejandro","position":1,"cik":"0001758494","reported_name":"Miller Eric Alejandro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Controller & PAO"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-09-11T23:19:29.000Z","date":"2019-09-09","kind":"exercise","acquired":false,"shares":4593,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"25% of the shares subject to the Stock Option vested and became exercisable on September 7, 2018, and the remaining shares vest and become exercisable in 36 equal monthly installments thereafter."}],"balance_after":4594,"derivative":{"exercise_price":35.8,"expiration_date":"2027-09-06","underlying":"Common Stock","underlying_shares":4593},"source":{"system":"sec-edgar","filing":"0001209191-19-049231","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919119049231/doc4.xml","form_type":"4"}},{"id":3417836,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":154409,"kind":"person","name":"Miller Eric Alejandro","position":1,"cik":"0001758494","reported_name":"Miller Eric Alejandro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Controller & PAO"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-09-11T23:19:29.000Z","date":"2019-09-09","kind":"exercise","acquired":false,"shares":4439,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"25% of the shares subject to the Stock Option vested and became exercisable on March 8, 2018, and the remaining shares vest and become exercisable in 36 equal monthly installments thereafter."}],"balance_after":2911,"derivative":{"exercise_price":36.54,"expiration_date":"2027-03-07","underlying":"Common Stock","underlying_shares":4439},"source":{"system":"sec-edgar","filing":"0001209191-19-049231","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919119049231/doc4.xml","form_type":"4"}},{"id":3417835,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":154409,"kind":"person","name":"Miller Eric Alejandro","position":1,"cik":"0001758494","reported_name":"Miller Eric Alejandro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Controller & PAO"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-09-11T23:19:29.000Z","date":"2019-09-09","kind":"exercise","acquired":false,"shares":6063,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"25% of the shares subject to the Stock Option vested and became exercisable on January 1, 2017, and the remaining shares vest and become exercisable in 36 equal monthly installments thereafter."}],"balance_after":552,"derivative":{"exercise_price":29.24,"expiration_date":"2026-01-05","underlying":"Common Stock","underlying_shares":6063},"source":{"system":"sec-edgar","filing":"0001209191-19-049231","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919119049231/doc4.xml","form_type":"4"}},{"id":3417834,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":154409,"kind":"person","name":"Miller Eric Alejandro","position":1,"cik":"0001758494","reported_name":"Miller Eric Alejandro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Controller & PAO"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-09-11T23:19:29.000Z","date":"2019-09-09","kind":"exercise","acquired":false,"shares":3900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":32.28,"expiration_date":"2025-01-25","underlying":"Common Stock","underlying_shares":3900},"source":{"system":"sec-edgar","filing":"0001209191-19-049231","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919119049231/doc4.xml","form_type":"4"}},{"id":3417833,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":154409,"kind":"person","name":"Miller Eric Alejandro","position":1,"cik":"0001758494","reported_name":"Miller Eric Alejandro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Controller & PAO"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-09-11T23:19:29.000Z","date":"2019-09-09","kind":"exercise","acquired":false,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":20.65,"expiration_date":"2024-05-29","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001209191-19-049231","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919119049231/doc4.xml","form_type":"4"}},{"id":3417832,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":154409,"kind":"person","name":"Miller Eric Alejandro","position":1,"cik":"0001758494","reported_name":"Miller Eric Alejandro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Controller & PAO"}}],"security":"Common Stock","published_at":"2019-09-11T23:19:29.000Z","date":"2019-09-11","kind":"sale","acquired":false,"shares":4645,"price":41.18,"value":191281.1,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.1401 to $41.255, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-19-049231","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919119049231/doc4.xml","form_type":"4"}},{"id":3417831,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":154409,"kind":"person","name":"Miller Eric Alejandro","position":1,"cik":"0001758494","reported_name":"Miller Eric Alejandro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Controller & PAO"}}],"security":"Common Stock","published_at":"2019-09-11T23:19:29.000Z","date":"2019-09-09","kind":"sale","acquired":false,"shares":28467,"price":39.49,"value":1124161.83,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.49 to $39.58, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":4645,"source":{"system":"sec-edgar","filing":"0001209191-19-049231","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919119049231/doc4.xml","form_type":"4"}},{"id":3417830,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":154409,"kind":"person","name":"Miller Eric Alejandro","position":1,"cik":"0001758494","reported_name":"Miller Eric Alejandro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Controller & PAO"}}],"security":"Common Stock","published_at":"2019-09-11T23:19:29.000Z","date":"2019-09-09","kind":"exercise","acquired":true,"shares":1972,"price":16.5,"value":32538.0,"ownership":{"direct":true},"balance_after":33112,"source":{"system":"sec-edgar","filing":"0001209191-19-049231","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919119049231/doc4.xml","form_type":"4"}},{"id":3417829,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":154409,"kind":"person","name":"Miller Eric Alejandro","position":1,"cik":"0001758494","reported_name":"Miller Eric Alejandro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Controller & PAO"}}],"security":"Common Stock","published_at":"2019-09-11T23:19:29.000Z","date":"2019-09-09","kind":"exercise","acquired":true,"shares":4593,"price":35.8,"value":164429.4,"ownership":{"direct":true},"balance_after":31140,"source":{"system":"sec-edgar","filing":"0001209191-19-049231","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919119049231/doc4.xml","form_type":"4"}},{"id":3417828,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":154409,"kind":"person","name":"Miller Eric Alejandro","position":1,"cik":"0001758494","reported_name":"Miller Eric Alejandro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Controller & PAO"}}],"security":"Common Stock","published_at":"2019-09-11T23:19:29.000Z","date":"2019-09-09","kind":"exercise","acquired":true,"shares":4439,"price":36.54,"value":162201.06,"ownership":{"direct":true},"balance_after":26547,"source":{"system":"sec-edgar","filing":"0001209191-19-049231","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919119049231/doc4.xml","form_type":"4"}},{"id":3417827,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":154409,"kind":"person","name":"Miller Eric Alejandro","position":1,"cik":"0001758494","reported_name":"Miller Eric Alejandro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Controller & PAO"}}],"security":"Common Stock","published_at":"2019-09-11T23:19:29.000Z","date":"2019-09-09","kind":"exercise","acquired":true,"shares":6063,"price":29.24,"value":177282.12,"ownership":{"direct":true},"balance_after":22108,"source":{"system":"sec-edgar","filing":"0001209191-19-049231","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919119049231/doc4.xml","form_type":"4"}},{"id":3417826,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":154409,"kind":"person","name":"Miller Eric Alejandro","position":1,"cik":"0001758494","reported_name":"Miller Eric Alejandro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Controller & PAO"}}],"security":"Common Stock","published_at":"2019-09-11T23:19:29.000Z","date":"2019-09-09","kind":"exercise","acquired":true,"shares":3900,"price":32.28,"value":125892.0,"ownership":{"direct":true},"balance_after":16045,"source":{"system":"sec-edgar","filing":"0001209191-19-049231","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919119049231/doc4.xml","form_type":"4"}},{"id":3417825,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":154409,"kind":"person","name":"Miller Eric Alejandro","position":1,"cik":"0001758494","reported_name":"Miller Eric Alejandro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Controller & PAO"}}],"security":"Common Stock","published_at":"2019-09-11T23:19:29.000Z","date":"2019-09-09","kind":"exercise","acquired":true,"shares":7500,"price":20.65,"value":154875.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 860 shares of the Issuer's common stock acquired by the reporting person on November 15, 2018 and 573 shares of the Issuer's common stock acquired by the reporting person on May 15, 2019 pursuant to an employee stock purchase program."}],"balance_after":12145,"source":{"system":"sec-edgar","filing":"0001209191-19-049231","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919119049231/doc4.xml","form_type":"4"}},{"id":3544603,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":154409,"kind":"person","name":"Miller Eric Alejandro","position":1,"cik":"0001758494","reported_name":"Miller Eric Alejandro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Controller & PAO"}}],"security":"Restricted Stock Units","published_at":"2019-05-01T22:02:40.000Z","date":"2019-04-29","kind":"grant","acquired":true,"shares":3442,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of ACADIA common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning April 29, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning April 29, 2020."}],"balance_after":3442,"derivative":{"underlying":"Common Stock","underlying_shares":3442},"source":{"system":"sec-edgar","filing":"0001209191-19-026848","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919119026848/doc4.xml","form_type":"4"}},{"id":3544602,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":154409,"kind":"person","name":"Miller Eric Alejandro","position":1,"cik":"0001758494","reported_name":"Miller Eric Alejandro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Controller & PAO"}}],"security":"Stock Options (Right to Buy)","published_at":"2019-05-01T22:02:40.000Z","date":"2019-04-29","kind":"grant","acquired":true,"shares":6039,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the Stock Option will vest and become exercisable on April 29, 2020. The remaining shares vest and become exercisable in 36 equal monthly installments thereafter."}],"balance_after":6039,"derivative":{"exercise_price":25.12,"expiration_date":"2029-04-29","underlying":"Common Stock","underlying_shares":6039},"source":{"system":"sec-edgar","filing":"0001209191-19-026848","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919119026848/doc4.xml","form_type":"4"}}]}